IP Library › Granted Patent US 7,557,082
Granted Patent B2
US 7,557,082 · App. 11/681,152 · Granted Jul 7, 2009

Treatment with cyclosporin A

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,557,082
App. No.
11/681,152
Granted
Jul 7, 2009
Kind
B2
Abstract

Disclosed herein is a method comprising administering cyclosporin A topically to an eye of a person for the purpose of treating or preventing loss of vision from keratoconus.

Claims (7)

1. A method of treating thinning of the cornea, comprising administering cyclosporin A topically to an eye of a person in need thereof.

2. The method of claim 1 wherein said thinning of the cornea causes distortion of the shape of the cornea.

3. The method of claim 2 wherein said distortion of the shape of the cornea is keratoconus.

4. The method of claim 2 wherein said distortion of the shape of the cornea is keratoglobus.

5. The method of claim 2 wherein said distortion of the shape of the cornea is Pellucid marginal degeneration.

6. The method of claim 1 , wherein cyclosporin A is administered daily for at least 6 months.

7. The method of claim 1 , wherein cyclosporin A is administered daily for at least 2 years.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 12, 2017
From: ALLERGAN, INC.
To: SAINT REGIS MOHAWK TRIBE
Reel/Frame 043830/0446 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 6, 2009
From: SCHIFFMAN, RHETT M.
To: ALLERGAN, INC.
Reel/Frame 022950/0481 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 29, 2008
From: SCHIFFMAN, RHETT M.
To: ALLERGAN, INC.
Reel/Frame 020871/0225 →